---
# Feel free to add content and custom Front Matter to this file.
# To modify the layout, see https://jekyllrb.com/docs/themes/#overriding-theme-defaults

layout: default
---

<br>
## About Me
<br>
<img class="profile-picture" src="self-portrait2.JPG">

Hello! I am an organic chemist with a BSc and PhD in Chemistry from the [University of Wisconsin-Milwaukee](https://uwm.edu/chemistry/our-people/saxon-eron/). I am currently seeking a job in the field of chemistry. Contact me if you are interested in hiring me, or have questions about my work.
<br>
<br>
## PhD Dissertation

> <i>Boron-based theranostics and prodrugs: design, synthesis, mechanism and biological investigation</i> 
(2024, <a href="https://dc.uwm.edu/etd/3513/">UWM Digital Commons</a>)

<html>
<head>
    <style>
        * {
            margin: 0;
            padding: 0;
        }
        .imgbox {
            display: grid;
            height: 95%;
        }
        .center-fit {
            max-width: 95%;
            max-height: 95vh;
            margin: auto;
        }
    </style>
</head>
<body>
<div class="imgbox">
    <img class="center-fit" src='theranostic-compounds.png'>
</div>
</body>
</html>

<br>
## Employment Experience
<br>
**1. Quality Control Lab Technician** (January 2018 – April 2019) <br>
    Company: <a href="https://www.metaltek.com/"> MetalTek International</a>; &nbsp;&nbsp;Location: Waukesha, WI
<ul>
    <br>
<li>Operated analytical instruments, including LECO carbon/sulfur and nitrogen/oxygen instruments, x-ray, and arc optical emission spectrometers</li>
<li>Maintained and standardized instruments following Nadcap (National Aerospace and Defense Contractors Accreditation Program) approved protocols</li>
<li>Performed routine analysis of heterogeneous metals for determination of elemental composition</li>
</ul>
<br>
**2. Research and Teaching Assistant** (September 2019 – May 2024) <br>
University of Wisconsin–Milwaukee;&nbsp;&nbsp; Advisor: <a href="https://uwm.edu/chemistry/our-people/peng-xiaohua/">Prof. Peng</a>;&nbsp;&nbsp; Location: Milwaukee, WI<br>
<ul>
<br>
<li>Designed novel theranostic and prodrug nitrogen mustards as anticancer small
molecules</li>
<li>Isolated and purified compounds by column chromatography, distillation, precipitation, recrystallization, and trituration resulting in 4 novel theranostics</li>
<li>Characterized compounds by utilizing TLC, NMR, LCMS, HRMS Q-TOF, UV/VIS,
fluorescence, and fluorescence confocal microscope instruments</li>
<li>Evaluated theranostics and prodrugs using cytotoxicity and fluorescence colocalization assays <i>in vitro</i> with TNBC MDA-MB-468 cell line</li>
<li>Synthesized oligonucleotides by automated solid-phase synthesis with ABI 394,
purification and <sup>32</sup>P radiolabeling of oligo for DNA interstrand cross-linking assays</li>

<html>
<head>
    <style>
        * {
            margin: 0;
            padding: 0;
        }
        .imgbox2 {
            display: grid;
            height: 80%;
        }
        .center-fit2 {
            max-width: 80%;
            max-height: 80vh;
            margin: auto;
        }
    </style>
</head>
<body>
<div class="imgbox2">
    <img class="center-fit2" src='synthetic-49mer-radiolabeled.png'>
</div>
</body>
</html>
<li>Determined safety and anticancer efficacy of compounds in <i>in vivo</i> CD1 and xenograft athymic mice study following IACUC approved guidelines</li>
<li>Determined physiochemical properties of small molecules (solubility and permeability)</li>
<li>Determined photophysical properties of fluorescent dyes</li>
<li>Determined prodrug activation mechanism <i>in vitro</i> and <i>in vivo</i> through deuterium isotope-labeled mustard prodrugs </li>
</ul>

<html>
<head>
    <style>
        * {
            margin: 0;
            padding: 0;
        }
        .imgbox-second {
            display: grid;
            height: 33%;
        }
        .center-fit-second {
            max-width: 33%;
            max-height: 33vh;
            margin: auto;
        }
    </style>
</head>
<body>
<div class="imgbox-second">
    <img class="center-fit-second" src='prodrug-compounds.png'>
</div>
</body>
</html>

<br>
<br>
**3. Research Volunteer** (June 2024 – Current)<br>
University of Wisconsin–Milwaukee;&nbsp;&nbsp; Advisor:<a href="https://uwm.edu/chemistry/our-people/peng-xiaohua/"> Prof. Peng</a>;&nbsp;&nbsp; Location: Milwaukee, WI<br>
<ul>
<li>Investigation of novel small molecule prodrugs and theranostics as selective anticancer and/or fluorogenic agents</li>
<br>
<br>
</ul>

## Skills
<br>
<ul>
<li>Synthetic organic chemistry, laboratory techniques and instrumentation</li> <li>Multi-step synthetic routes (>13 steps) of oxygen-,water-, light-sensitive reaction conditions</li> 
<li>Click CuAAC, heterocycle and boron chemistry</li> 
<li>Biochemistry and biological assays: <i>in vitro</i> cell cultures and <i>in vivo</i> mice models</li> 
<li>Knowledge of anticancer drug development process</li> 
<li>Microsoft Office, ChemDraw, ChemSketch, SciFinder, Reaxys, Shimadzu LabSolutions, Bruker TopSpin, ImageJ, Zeiss Zen, QuPath and GraphPad Prism</li> 
</ul>
<br>

## Auxiliary Skills
<br>
<ul>
<li>Ability to maintain lab safety, lab cleanliness, lab notebook and meet deadlines</li> 
<li>Ability to rationally design and synthesize organic molecules </li> 
<li>Self-motivated and detail-oriented </li> 
<br>
</ul>

## Publications
<br>
<ul>
<li>Fan, H.; Zaman, M. A. U.; Chen, W.; Ali, T.; Campbell, A.; Zhang, Q.; Setu, N. I.; <b>Saxon, E.</b>; Zahn, N. M.; Benko, A. M.; Arnold, L. A.; Peng, X., Assessment of Phenylboronic Acid Nitrogen Mustards as Potent and Selective Drug Candidates for Triple-Negative Breast Cancer. <i>ACS Pharmacol. Transl. Sci.</i> 2021, 4 (2), 687-702, <a href="https://pubs.acs.org/doi/10.1021/acsptsci.0c00092">doi.org/10.1021/acsptsci.0c00092</a></li>
<li><b>Saxon, E.</b>; Peng, X. (2021), Recent Advances in Hydrogen Peroxide Responsive Organoborons for Biological and Biomedical Applications. <i>ChemBioChem</i>. 2021, <a href="https://doi.org/10.1002/cbic.202100366">doi.org/10.1002/cbic.202100366</a></li> 
<li><b>Saxon, E.</b>; Ali, T.; Peng, X. (2024), Hydrogen Peroxide Responsive Theranostics for Cancer-Selective Activation of DNA Alkylators and Real-Time Fluorescence Monitoring in Living Cells. <i>Eur. J. Med. Chem.</i> 2024, <a href="https://www.sciencedirect.com/science/article/abs/pii/S0223523424005750?via%3Dihub">doi.org/10.1016/j.ejmech.2024.116695</a></li> 
</ul> 
<br>
<br>

## Presentations
<br>
<ul>
<li>Saxon E., Peng X., DNA Sequencing: Modern Techniques and Application (2020). UWM Graduate Seminar, Milwaukee WI.</li>
<li>Saxon E., Peng X., Synthesis of a Novel Phenyl Boronic Ester Nitrogen Mustard Analog (2021). Poster at the UWM Spring Symposium, Milwaukee WI.</li>
<li>Saxon, E., Peng, X. Biological Application of a Novel DNA-Alkylating Theranostic Agent (2022). Poster at the <a href="https://acs.digitellinc.com/b/sp/eron-saxon-323319">ACS Fall 2022 Conference</a>, Chicago IL.</li>
<li>Saxon E., Peng X., Synthesis and Application of a Novel DNA Alkylating Theranostic Agent. (2022). Seminar at the UW-Milwaukee Institute for Drug Discovery Symposium, Milwaukee WI.</li>
</ul> 
<br>
<br>

## Awards<br>
<br>
<ul>
<li>UWM Chancellor’s Award (2019 – 2022)</li>
<li>
UWM Graduate School Distinguished Dissertation Fellowship <a href="https://uwm.edu/chemistry/phd-candidate-eron-saxon-receives-the-2023-24-distinguished-dissertation-fellowship-ddf-award/">(DDF) Award</a> (2023 – 2024)</li>
</ul>
<br>
<br>
## Patent<br>
<ul>
<br>
<li>Peng, X.; Saxon, E., Hydrogen Peroxide Responsive Theranostics. Patent Application 2024, US provisional patent No. 020871-0017-US01</li>
</ul> 
<br>
<br>